genom
proteom
approach
studi
fundament
cell
mechan
rapidli
contribut
broaden
knowledg
metabol
pathway
optim
exploit
cell
factori
last
year
knowledg
led
import
advanc
larg
scale
product
diagnost
therapeut
protein
heterolog
host
bacteria
yeast
mammalian
insect
cell
transgen
anim
plant
allow
comparison
effici
method
term
cost
product
qualiti
safeti
vaccinolog
rapidli
expand
research
field
new
vaccin
strategi
develop
thank
modern
technolog
base
ration
design
attenu
pathogen
live
recombin
vaccin
protein
antigen
peptid
epitop
base
subunit
vaccin
plotkin
aim
approach
obtain
effici
safe
vaccin
formul
abl
time
induc
effect
long
last
immun
complex
viral
pathogen
nabel
influenza
viru
stephenson
et
al
sarscoronaviru
stadler
rappuoli
reach
goal
target
must
found
abl
gener
longterm
memori
b
cell
produc
neutral
antibodi
block
free
pathogen
also
cell
mediat
immun
control
pathogen
spread
elimin
infect
cell
lambert
et
al
newborn
branch
plant
biotechnolog
defin
molecular
farm
mainli
focus
exploit
plant
agronom
relev
factori
larg
scale
product
biomolecul
possibl
produc
subunit
vaccin
plant
pave
new
way
offer
solut
problem
associ
tradit
product
system
stabl
express
heterolog
protein
plant
perform
insert
exogen
encod
gene
nuclear
plastid
genom
obtain
plant
transform
nuclear
genom
natur
capabl
agrobacterium
tumefacien
transfer
dna
plant
cell
tinland
ampli
exploit
method
plant
tissu
transform
either
vitro
small
leaf
explant
directli
planta
feldmann
mark
bechtold
pelleti
clough
bent
transform
plant
speci
less
suscept
pathogen
ie
monocot
also
achiev
shoot
dnacoat
tungsten
gold
microbead
plant
tissu
particl
gun
biolist
method
taylor
fauquet
sever
antigen
success
express
plant
stabl
nuclear
transform
differ
end
case
plant
consid
biofactori
massiv
product
other
edibl
plant
varieti
chosen
direct
oral
deliveri
express
antigen
tabl
antigen
transgen
plant
refer
use
plant
inde
repres
measur
reduc
product
cost
improv
product
safeti
elimin
use
needl
also
strategi
effici
deliv
vaccin
mucos
level
tacket
et
al
kapusta
et
al
tacket
et
al
tacket
et
al
thanavala
et
al
nonetheless
antigen
product
plant
still
suffer
limit
nuclear
transform
technolog
basic
due
low
variabl
express
level
heterolog
gene
among
independ
line
particularli
detriment
direct
oral
deliveri
plant
tissu
foreseen
precis
priori
establish
vaccin
dose
impractic
step
taken
face
problem
consist
optim
heterolog
gene
sequenc
use
host
codon
usag
remov
cryptic
genet
signal
neg
affect
posttransl
step
target
heterolog
protein
appropri
subcellular
compart
ensur
proper
fold
identifi
suitabl
regulatori
element
abl
ensur
reproduc
highlevel
tissuespecif
transgen
express
shown
activ
nomin
constitut
promot
vari
function
development
stage
organ
plant
speci
williamson
et
al
malik
et
al
samac
et
al
recent
new
plantderiv
regulatori
sequenc
promotertermin
sullivan
green
koziel
et
al
gomez
et
al
tuboli
et
al
streatfield
et
al
bold
charact
indic
refer
describ
clinic
trial
plantexpress
antigen
highli
transcrib
gene
carboxylas
rbc
smallsubunit
gene
famili
chrysanthemum
outchkourov
et
al
regulatori
sequenc
seed
storag
protein
gene
arcelin
common
bean
phaseolu
vulgari
de
jaeger
et
al
novel
gene
regulatori
element
associ
cryptic
constitut
promot
tobacco
malik
et
al
identifi
sequenc
current
use
improv
transgen
express
level
differ
plant
speci
turn
similar
direct
approach
aim
product
transgen
plant
line
stabli
encod
replic
viral
vector
socal
replicon
amplicon
express
uniformli
synchron
foreign
gene
thank
effici
viral
replicas
palmer
et
al
mallori
et
al
gleba
et
al
zhang
mason
agrobacterium
tdna
insert
target
site
evalu
whether
transgen
express
variabl
singl
copi
transgen
plant
correl
integr
posit
gelvin
de
buck
et
al
schneeberg
et
al
similar
direct
effort
orient
attempt
adjust
gene
target
homolog
recombin
plant
induc
integr
heterolog
gene
predetermin
genom
locat
fundament
plant
metabol
anomal
express
profil
due
posttranscript
silenc
hanin
paszkowski
srivastava
ow
progress
sens
achiev
use
crelox
mediat
recombin
mainli
tobacco
rice
latter
case
optim
design
tdna
flank
region
albert
et
al
terada
et
al
cotsafti
guiderdoni
interest
altern
nuclear
stabl
transform
insert
antigen
encod
gene
plastid
genom
tregon
et
al
koya
et
al
molina
et
al
glenz
et
al
fundament
differ
plastid
nuclear
transform
plastid
homolog
recombin
foreign
sequenc
feasibl
elimin
problem
link
posit
effect
moreov
plastid
genom
present
sever
copi
singl
cell
rapidli
replic
ensur
high
yield
recombin
protein
product
despit
advantag
data
avail
regard
oral
deliveri
transplastom
plant
tissu
probabl
fertil
edibl
transplastom
plant
still
construct
ruf
et
al
lelivelt
et
al
altern
effort
made
point
prefer
singl
copi
pattern
prevent
accident
inactiv
gene
get
round
difficulti
encount
obtain
high
rate
express
heterolog
gene
nuclear
transform
plant
transient
transform
strategi
devis
case
gene
encod
antigen
interest
insert
genom
pathogen
use
vector
express
plant
infect
two
major
techniqu
use
get
transient
transform
base
plant
virusesor
agrobacteriummedi
infect
fulli
develop
plant
use
plant
virus
typic
ss
rna
virus
tobacco
mosaic
viru
tmv
cowpea
mosaic
viru
cpmv
potato
viru
x
pvx
alfalfa
mosaic
viru
almv
transient
express
heterolog
gene
greatli
favor
develop
express
vector
harbor
cdna
complet
viral
genom
pogu
et
al
use
tool
foreign
gene
easili
insert
addit
open
read
frame
orf
possibl
replac
unessenti
viral
function
lacomm
et
al
way
mani
antigen
success
produc
abl
induc
anim
model
good
antibodi
respons
deliv
extract
antigen
viral
vector
refer
viral
vector
purifi
form
directli
per
os
use
infect
plant
tissu
tabl
pathogen
antigen
viral
vector
agroinfiltr
techniqu
use
mainli
predict
express
effici
construct
use
nuclear
stabl
transform
howev
recent
approach
convert
procedur
valuabl
altern
express
system
exampl
icon
genet
inc
recent
acquir
bayer
develop
system
magnicon
overexpress
foreign
gene
conjug
effici
agrobacteriummedi
transform
viral
rate
express
gil
et
al
strategi
base
optim
tmv
genom
remov
cryptic
sequenc
recogn
plant
machineri
could
affect
viral
replicationspread
split
improv
genom
modul
express
modul
includ
viral
polymeras
movement
protein
gene
modul
carri
gene
interest
substitut
viral
coat
protein
gene
two
modul
use
coinfiltr
plant
link
togeth
recombinas
encod
third
coinfiltr
vector
recogn
specif
recombinas
targetsequ
artifici
ad
modul
deconstruct
viru
system
lack
coat
protein
gene
unabl
spread
throughout
plant
environ
influenc
dimens
insert
gene
due
absenc
packag
process
lead
plant
cell
machineri
product
heterolog
protein
use
strategi
high
level
differ
yersinia
pesti
antigen
express
nicotiana
benthamiana
plant
plantproduc
antigen
effici
induc
protect
immun
respons
pathogen
administ
subcutan
guinea
pig
santi
et
al
antigen
receptor
b
cell
respons
induct
immun
respons
use
synthet
peptid
correspond
sequenc
linear
epitop
consid
develop
safe
vaccin
unfortun
efficaci
peptid
induct
immun
respons
limit
mainli
short
halflif
serum
sever
deliveri
system
design
circumv
limit
attract
approach
produc
epitopebas
plant
vaccin
construct
chimer
plant
virus
display
surfac
assembl
particl
peptid
interest
vaccin
formul
pogu
et
al
approach
plant
employ
biofactori
larg
scale
reservoir
chimer
viru
particl
cvp
carri
epitop
construct
cvp
sequenc
code
heterolog
peptid
fuse
viral
coat
protein
cp
gene
posit
known
expos
viral
surfac
johnson
et
al
porta
lomonossoff
guarante
product
larg
quantiti
cvp
structur
function
character
cp
essenti
place
foreign
peptid
avoid
interfer
viral
assembl
stabil
andor
spread
plant
aim
fundament
studi
defin
biochem
factor
govern
viral
movement
cpviru
particl
structur
mutat
immunolog
xray
diffractionspectrometri
analysi
carrington
et
al
callaway
et
al
bendahman
et
al
porta
et
al
efficaci
cvp
induc
antibodi
respons
specif
display
epitop
extens
demonstr
purifi
cvp
administ
anim
model
intranas
intraperiton
oral
direct
deliveri
virusinfect
plant
tissu
case
also
human
abl
induc
strong
specif
neutral
immun
recent
data
indic
cvp
could
abl
induc
also
activ
hla
class
restrict
cell
respons
natur
killer
cell
yusibov
et
al
endors
find
envisag
signific
expans
plant
deriv
cvp
field
vaccinolog
respons
tabl
epitop
import
part
antigen
interact
although
subunit
vaccin
offer
great
perspect
develop
somewhat
impair
due
fact
peptid
protein
poorli
immunogen
andor
unabl
properli
present
cytotox
cell
sett
fike
reason
asid
identif
essenti
target
effort
focus
improv
vaccin
efficaci
far
recombin
antigenbas
formul
concern
fundament
role
play
substanc
abl
enhanc
immun
respons
antigen
fundament
strengthen
efficaci
activ
principl
vaccin
adjuv
cox
coulter
research
current
progress
area
nonetheless
aluminium
salt
first
adjuv
describ
glenni
et
al
still
remain
standard
human
use
plant
also
consid
possibl
sourc
adjuv
known
plantderiv
adjuv
saponin
particular
acyl
triterpen
saponin
extract
bark
south
american
tree
quillaja
saponaria
molina
jacobsen
et
al
basic
interest
natur
surfact
deriv
high
water
solubl
stabil
hour
day
mixtur
antigen
prepar
deliv
combin
differ
antigen
sever
anim
model
also
human
trial
abl
enhanc
respons
moor
et
al
favor
activ
cytotox
cell
newman
et
al
besid
new
variant
natur
semisynthet
saponin
da
silva
et
al
marciani
et
al
broad
rang
differ
plantderiv
compound
neem
tree
leaf
prepar
nlp
baral
et
al
compound
chines
herbal
medicin
ingredi
cchmi
fraction
ginseng
rivera
et
al
investig
evalu
adjuvant
compound
togeth
molecul
triterpenoid
squalen
moment
sole
adjuv
togeth
alum
approv
human
use
singh
ohagan
stephenson
et
al
effect
freund
complet
incomplet
adjuv
abl
induc
balanc
immun
respons
activ
immun
even
toward
tumor
antigen
baral
et
al
asid
identif
immun
respons
potenti
new
rout
deliveri
altern
deliveri
strategi
also
consid
key
factor
improv
subunit
vaccin
efficaci
mucos
immun
exampl
repres
effici
altern
tradit
parenter
immun
induc
secretori
iga
respons
also
system
antibodi
product
tcell
mediat
immun
holmgren
czerkinski
moreov
noninvas
easydeliv
immun
procedur
perform
without
use
needl
thu
prevent
crosscontamin
plantderiv
antigen
stabli
transient
express
edibl
tissuesorgan
deliv
oral
effici
immun
procedur
evalu
term
antibodi
product
context
chimer
plant
viru
particl
offer
interest
solut
problem
peptidevaccin
efficaci
two
main
reason
function
carrier
peptidedeliveri
demonstr
effici
immun
responseinduc
without
need
adjuv
deliv
purifi
form
marus
et
al
oral
administ
infect
plant
tissu
yusibov
et
al
studi
carri
order
defin
fate
cvp
vivo
investig
distribut
mice
cpmv
particl
oral
intraven
deliv
rae
et
al
conclus
icosahedr
virion
best
character
use
nanoparticl
wang
et
al
wang
et
al
chatterji
et
al
stabl
transit
gastrointestin
tract
abl
dissemin
system
thereaft
cpmv
particl
found
sever
tissu
throughout
bodi
support
idea
use
also
oral
bioavail
nanocapsul
deliveri
vaccin
gener
therapeut
two
centuri
pass
edward
jenner
first
vaccin
smallpox
sinc
mani
advanc
scientif
conquest
done
field
vaccinolog
howev
despit
progress
lot
frequent
second
less
import
socioeconom
issu
excess
cost
avail
vaccin
prevent
applic
guidelin
tend
cancel
dispar
health
right
still
exist
among
industri
develop
countri
use
plant
biofactori
could
offer
solut
problem
delic
issu
still
subsist
first
biolog
safeti
product
advers
effect
vaccin
deliveri
unfortun
plant
mainli
consid
attract
altern
system
product
subunit
vaccin
give
emphasi
advantag
term
costreduct
intrins
biolog
safeti
product
howev
mani
indic
suggest
effort
concentr
defin
plant
could
exploit
novel
strategi
subunit
epitop
vaccin
deliveri
could
enhanc
effici
vaccin
improv
global
health
equiti
favour
diffus
modern
vaccin
world
poorest
countri
obviou
question
friendli
promis
technolog
difficulti
take
capit
invest
sector
still
limit
